Actionnariat et activité des initiés pour NextCure, Inc. (NXTC): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $6.03 |
| Capitalisation | $22M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $8.4M | $135.2M | $34.1M | $32.8M | $12.3M | $26.6M | $13.1M | $27.7M | $26.0M |
| Placements à Court Terme | 0 | 0 | $300.5M | $250.7M | $207.3M | $133.3M | $95.2M | $40.9M | $15.8M |
| Créances | 0 | 0 | 0 | 0 | 0 | $700000 | $800000 | $300000 | $100000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | -$700000 | 0 | 0 | 0 |
| Actifs Courants | $9.4M | $135.8M | $340.0M | $288.0M | $227.8M | $164.0M | $112.7M | $71.8M | $43.7M |
| Immobilisations Corporelles | $10.0M | $11.4M | $12.1M | $15.8M | $14.0M | $16.9M | $13.4M | $8.7M | $5.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $19.5M | $147.6M | $356.2M | $306.6M | $242.4M | $184.2M | $128.0M | $80.9M | $50.2M |
| Dettes Fournisseurs | $1.1M | $2.5M | $1.9M | $3.9M | $1.9M | $4.3M | $2.3M | $5.4M | $2.0M |
| Dette à Court Terme | $400000 | $387000 | $1.7M | $1.7M | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $3.1M | $10.3M | $15.0M | $10.3M | $6.6M | $9.1M | $6.9M | $9.6M | $10.6M |
| Dette à Long Terme | $460000 | $73000 | $3.3M | $1.8M | 0 | 0 | 0 | 0 | $4.1M |
| Passifs Totaux | $43.9M | $194.6M | $34.7M | $12.9M | $9.0M | $16.6M | $13.6M | $15.4M | $15.2M |
| Réserves | -$24.5M | -$47.3M | -$81.0M | -$117.6M | -$187.0M | -$261.8M | -$324.5M | -$380.1M | -$436.0M |
| Capitaux Propres | -$24.4M | -$46.9M | $321.5M | $293.7M | $233.4M | $167.5M | $114.4M | $65.5M | $34.9M |
| Dette Totale | $964000 | $587000 | $5.1M | $3.5M | 0 | $7.1M | $6.6M | $5.9M | $5.2M |
| Dette Nette | -$7.5M | -$134.6M | -$329.5M | -$280.0M | -$219.6M | -$152.8M | -$101.7M | -$62.7M | -$36.7M |
| Fonds de Roulement | $6.3M | $125.5M | $325.0M | $277.7M | $221.2M | $154.9M | $105.8M | $62.2M | $33.2M |
Santé financière
| Dette / Capitaux propres | 0.35 |
| Ratio de liquidité | 3.47 |
Rentabilité
| Rentabilité des capitaux propres | -175.46% |
| Rentabilité du capital investi | -259.91% |
| Rentabilité des actifs | -188.98% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ANTX · BOLD · INTS · ITRM · JSPR · PLUR · PSTV
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de NXTC: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions